Harnessing artificial intelligence to control drug-resistant epilepsy
Epilepsy affects nearly one percent of the global population, making it one of the most common neurological disorders. While two-thirds of patients with epilepsy respond well to pharmacological treatment or are eligible for ...
Dec 4, 2018
0
9